Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPM2 pseudogene 1 (TPM2P1, LOC100130620) is a human pseudogene related to the TPM2 gene (Tropomyosin 2), which encodes the beta-tropomyosin protein involved in muscle contraction. As a pseudogene, TPM2P1 is generally considered non-functional for protein coding and does not encode a protein product. Pseudogenes like TPM2P1 may have regulatory RNA roles in some instances, but there is no specific evidence for any biological or disease function for TPM2P1. Therefore, TPM2P1 is not a therapeutic target and does not have an established role in disease or pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPM2 pseudogene 1 (TPM2P1).